Cigar Tobacco Reference Products Program (UC2) Clinical Trials Not Allowed

FDA's CTP is seeking to develop a cigar tobacco reference products program that will require significant collaboration and research efforts with outside organizations. The selected organization(s) will develop tobacco reference products representing at minimum three categories of commercially available cigars to be used for investigational nonclinical purposes by tobacco manufacturers, contract and government laboratories, and academic institutions. FDA's CTP will prioritize the cigar product types.